Attorneys general in 41 states and Washington, D.C., claim J&J and Ethicon knew medical complications could arise from using the device but didn’t adequately warn consumers or surgeons.
Transvaginal surgical mesh devices are used to treat pelvic organ prolapse, a condition that causes the bladder, bowel or uterus to shift, often after a hysterectomy, childbirth or menopause. Health complications linked to the devices include urinary dysfunction, loss of sexual function, constipation, pelvic pain and infection.
The settlement involves no admission of liability or misconduct from Ethicon.
Read the full article here.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
